Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey

Lisa Maher; Handan Wand; Sue Heard; Mitchell Starr; Farzaneh Zolala; Robert Kemp; Phillip Cunningham; Heidi Drummer; Margaret Hellard; John Kaldor; Gregory Dore

doi:10.1016/j.drugpo.2024.104545

Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey

Lisa Maher
, Handan Wand
, Sue Heard
, Mitchell Starr
, Farzaneh Zolala
, Robert Kemp
, Phillip Cunningham
, Heidi Drummer
, Margaret Hellard
, John Kaldor
, Gregory Dore

Research output: Contribution to journal › Article › Other › peer-review

3 Citations (Scopus)

Abstract

Publisher's Note:

Due to a production error, the following article was wrongly included as part of a regular issue, Volume 131C. This article is now replaced with this note and will be included in an upcoming special issue titled, “Biobehavioural Surveys”. Please refer to the DOI and citation details in that version when citing the paper. The Publisher apologizes for the inconvenience

Original language	English
Article number	104545
Number of pages	1
Journal	International Journal of Drug Policy
Volume	131
DOIs	https://doi.org/10.1016/j.drugpo.2024.104545
Publication status	Published - Sept 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Hepatitis C virus
Integrated bio-behavioural surveillance
People who inject drugs
Prevalence
Waning antibody

Access to Document

10.1016/j.drugpo.2024.104545

Cite this

Maher, L., Wand, H., Heard, S., Starr, M., Zolala, F., Kemp, R., Cunningham, P., Drummer, H., Hellard, M., Kaldor, J., & Dore, G. (2024). Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey. International Journal of Drug Policy, 131, Article 104545. https://doi.org/10.1016/j.drugpo.2024.104545

@article{d5fa52d2c2c543ad8d3619825f866623,

title = "Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey",

abstract = "Publisher's Note: Due to a production error, the following article was wrongly included as part of a regular issue, Volume 131C. This article is now replaced with this note and will be included in an upcoming special issue titled, “Biobehavioural Surveys”. Please refer to the DOI and citation details in that version when citing the paper. The Publisher apologizes for the inconvenience",

keywords = "Hepatitis C virus, Integrated bio-behavioural surveillance, People who inject drugs, Prevalence, Waning antibody",

author = "Lisa Maher and Handan Wand and Sue Heard and Mitchell Starr and Farzaneh Zolala and Robert Kemp and Phillip Cunningham and Heidi Drummer and Margaret Hellard and John Kaldor and Gregory Dore",

note = "Publisher Copyright: {\textcopyright} 2024",

year = "2024",

month = sep,

doi = "10.1016/j.drugpo.2024.104545",

language = "English",

volume = "131",

journal = "International Journal of Drug Policy",

issn = "0955-3959",

publisher = "Elsevier",

}

Maher, L, Wand, H, Heard, S, Starr, M, Zolala, F, Kemp, R, Cunningham, P, Drummer, H, Hellard, M, Kaldor, J & Dore, G 2024, 'Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey', International Journal of Drug Policy, vol. 131, 104545. https://doi.org/10.1016/j.drugpo.2024.104545

Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey. / Maher, Lisa; Wand, Handan; Heard, Sue et al.
In: International Journal of Drug Policy, Vol. 131, 104545, 09.2024.

Research output: Contribution to journal › Article › Other › peer-review

TY - JOUR

T1 - Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey

AU - Maher, Lisa

AU - Wand, Handan

AU - Heard, Sue

AU - Starr, Mitchell

AU - Zolala, Farzaneh

AU - Kemp, Robert

AU - Cunningham, Phillip

AU - Drummer, Heidi

AU - Hellard, Margaret

AU - Kaldor, John

AU - Dore, Gregory

PY - 2024/9

Y1 - 2024/9

N2 - Publisher's Note: Due to a production error, the following article was wrongly included as part of a regular issue, Volume 131C. This article is now replaced with this note and will be included in an upcoming special issue titled, “Biobehavioural Surveys”. Please refer to the DOI and citation details in that version when citing the paper. The Publisher apologizes for the inconvenience

AB - Publisher's Note: Due to a production error, the following article was wrongly included as part of a regular issue, Volume 131C. This article is now replaced with this note and will be included in an upcoming special issue titled, “Biobehavioural Surveys”. Please refer to the DOI and citation details in that version when citing the paper. The Publisher apologizes for the inconvenience

KW - Hepatitis C virus

KW - Integrated bio-behavioural surveillance

KW - People who inject drugs

KW - Prevalence

KW - Waning antibody

UR - https://www.scopus.com/pages/publications/85201520715

U2 - 10.1016/j.drugpo.2024.104545

DO - 10.1016/j.drugpo.2024.104545

M3 - Article

AN - SCOPUS:85201520715

SN - 0955-3959

VL - 131

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

M1 - 104545

ER -

Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey

Cite this